Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Supernus Pharmaceuticals (SUPN)

$40.77 +$0.07 (+0.17%)

Day’s range
$39.58–$40.87
Volume
930,902

SUPN price history

SUPN closed at $40.77 on Oct. 26, 2026. Over the past year, its daily close ranged from $37.88 on Oct. 16, 2026 to $57.00 on Nov. 4, 2025.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $35 to $60, not from zero.
Data table: SUPN daily closes, the past year
SUPN daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$40.77
Oct. 23, 2026$40.70
Oct. 22, 2026$42.07
Oct. 21, 2026$41.21
Oct. 20, 2026$41.23
Oct. 19, 2026$39.84
Oct. 16, 2026$37.88
Oct. 15, 2026$39.57
Oct. 14, 2026$40.18
Oct. 13, 2026$42.01
Oct. 12, 2026$42.81
Oct. 9, 2026$42.67
Oct. 8, 2026$42.14
Oct. 7, 2026$43.05
Oct. 6, 2026$42.83
Oct. 5, 2026$42.76
Oct. 2, 2026$42.38
Oct. 1, 2026$42.18
Sept. 30, 2026$43.04
Sept. 29, 2026$43.97
Sept. 28, 2026$44.60
Sept. 25, 2026$42.66
Sept. 24, 2026$43.29
Sept. 23, 2026$43.39
Sept. 22, 2026$43.75
Sept. 21, 2026$42.78
Sept. 18, 2026$42.00
Sept. 17, 2026$42.92
Sept. 16, 2026$41.38
Sept. 15, 2026$41.28
Sept. 14, 2026$41.49
Sept. 11, 2026$41.64
Sept. 10, 2026$41.69
Sept. 9, 2026$42.07
Sept. 8, 2026$42.43
Sept. 4, 2026$43.53
Sept. 3, 2026$43.97
Sept. 2, 2026$44.03
Sept. 1, 2026$43.74
Aug. 31, 2026$44.21
Aug. 28, 2026$43.73
Aug. 27, 2026$44.19
Aug. 26, 2026$44.88
Aug. 25, 2026$45.36
Aug. 24, 2026$45.11
Aug. 21, 2026$45.85
Aug. 20, 2026$47.45
Aug. 19, 2026$48.54
Aug. 18, 2026$49.03
Aug. 17, 2026$48.27
Aug. 14, 2026$48.27
Aug. 13, 2026$47.15
Aug. 12, 2026$47.87
Aug. 11, 2026$46.88
Aug. 10, 2026$47.07
Aug. 7, 2026$47.64
Aug. 6, 2026$46.76
Aug. 5, 2026$46.91
Aug. 4, 2026$43.25
Aug. 3, 2026$46.00
July 31, 2026$44.63
July 30, 2026$45.61
July 29, 2026$46.57
July 28, 2026$47.73
July 27, 2026$46.98
July 24, 2026$46.20
July 23, 2026$47.19
July 22, 2026$46.94
July 21, 2026$47.87
July 20, 2026$47.42
July 17, 2026$48.04
July 16, 2026$48.21
July 15, 2026$47.73
July 14, 2026$46.66
July 13, 2026$47.35
July 10, 2026$48.46
July 9, 2026$48.75
July 8, 2026$50.44
July 7, 2026$47.94
July 6, 2026$47.24
July 2, 2026$48.05
July 1, 2026$47.41
June 30, 2026$46.51
June 29, 2026$46.80
June 26, 2026$46.84
June 25, 2026$44.75
June 24, 2026$45.14
June 23, 2026$44.48
June 22, 2026$44.48
June 18, 2026$44.38
June 17, 2026$43.58
June 16, 2026$43.58
June 15, 2026$43.86
June 12, 2026$44.41
June 11, 2026$45.55
June 10, 2026$45.09
June 9, 2026$45.66
June 8, 2026$44.48
June 5, 2026$44.75
June 4, 2026$44.70
June 3, 2026$44.04
June 2, 2026$44.07
June 1, 2026$44.76
May 29, 2026$46.18
May 28, 2026$46.85
May 27, 2026$46.64
May 26, 2026$47.77
May 22, 2026$48.21
May 21, 2026$49.38
May 20, 2026$48.69
May 19, 2026$47.62
May 18, 2026$48.33
May 15, 2026$49.43
May 14, 2026$51.20
May 13, 2026$51.36
May 12, 2026$50.53
May 11, 2026$49.37
May 8, 2026$51.53
May 7, 2026$52.28
May 6, 2026$51.45
May 5, 2026$49.19
May 4, 2026$48.63
May 1, 2026$47.85
April 30, 2026$48.00
April 29, 2026$48.55
April 28, 2026$48.69
April 27, 2026$49.46
April 24, 2026$49.76
April 23, 2026$50.39
April 22, 2026$50.29
April 21, 2026$49.12
April 20, 2026$51.25
April 17, 2026$51.39
April 16, 2026$49.22
April 15, 2026$49.94
April 14, 2026$50.11
April 13, 2026$49.95
April 10, 2026$50.68
April 9, 2026$51.50
April 8, 2026$51.61
April 7, 2026$50.96
April 6, 2026$50.54
April 2, 2026$50.48
April 1, 2026$51.44
March 31, 2026$51.69
March 30, 2026$49.35
March 27, 2026$49.52
March 26, 2026$50.80
March 25, 2026$50.06
March 24, 2026$49.38
March 23, 2026$49.25
March 20, 2026$47.76
March 19, 2026$48.84
March 18, 2026$49.29
March 17, 2026$50.82
March 16, 2026$50.21
March 13, 2026$49.91
March 12, 2026$50.46
March 11, 2026$53.22
March 10, 2026$53.67
March 9, 2026$54.17
March 6, 2026$53.87
March 5, 2026$54.27
March 4, 2026$55.58
March 3, 2026$54.56
March 2, 2026$55.09
Feb. 27, 2026$54.73
Feb. 26, 2026$55.75
Feb. 25, 2026$56.32
Feb. 24, 2026$53.30
Feb. 23, 2026$50.69
Feb. 20, 2026$50.86
Feb. 19, 2026$51.35
Feb. 18, 2026$50.20
Feb. 17, 2026$51.62
Feb. 13, 2026$50.84
Feb. 12, 2026$49.85
Feb. 11, 2026$51.34
Feb. 10, 2026$51.18
Feb. 9, 2026$51.30
Feb. 6, 2026$51.65
Feb. 5, 2026$49.37
Feb. 4, 2026$49.08
Feb. 3, 2026$48.40
Feb. 2, 2026$48.78
Jan. 30, 2026$48.16
Jan. 29, 2026$49.06
Jan. 28, 2026$48.94
Jan. 27, 2026$49.44
Jan. 26, 2026$49.16
Jan. 23, 2026$48.25
Jan. 22, 2026$49.10
Jan. 21, 2026$49.52
Jan. 20, 2026$49.82
Jan. 16, 2026$50.00
Jan. 15, 2026$50.26
Jan. 14, 2026$51.80
Jan. 13, 2026$51.45
Jan. 12, 2026$51.36
Jan. 9, 2026$51.11
Jan. 8, 2026$51.17
Jan. 7, 2026$51.24
Jan. 6, 2026$49.26
Jan. 5, 2026$49.40
Jan. 2, 2026$49.47
Dec. 31, 2025$49.70
Dec. 30, 2025$49.89
Dec. 29, 2025$51.25
Dec. 26, 2025$51.57
Dec. 24, 2025$51.77
Dec. 23, 2025$51.71
Dec. 22, 2025$51.50
Dec. 19, 2025$51.48
Dec. 18, 2025$49.28
Dec. 17, 2025$48.75
Dec. 16, 2025$48.32
Dec. 15, 2025$47.28
Dec. 12, 2025$47.16
Dec. 11, 2025$46.51
Dec. 10, 2025$46.16
Dec. 9, 2025$45.42
Dec. 8, 2025$47.16
Dec. 5, 2025$45.68
Dec. 4, 2025$45.10
Dec. 3, 2025$44.76
Dec. 2, 2025$44.12
Dec. 1, 2025$44.70
Nov. 28, 2025$45.59
Nov. 26, 2025$46.26
Nov. 25, 2025$46.08
Nov. 24, 2025$45.15
Nov. 21, 2025$45.32
Nov. 20, 2025$44.79
Nov. 19, 2025$45.70
Nov. 18, 2025$44.90
Nov. 17, 2025$45.09
Nov. 14, 2025$45.00
Nov. 13, 2025$44.44
Nov. 12, 2025$44.62
Nov. 11, 2025$46.11
Nov. 10, 2025$45.40
Nov. 7, 2025$46.02
Nov. 6, 2025$47.27
Nov. 5, 2025$47.11
Nov. 4, 2025$57.00
Nov. 3, 2025$55.70
Oct. 31, 2025$55.13
Oct. 30, 2025$56.50
Oct. 29, 2025$55.68
Oct. 28, 2025$53.17
Oct. 27, 2025$52.72

Key figures

52-week range
$37.88–$57.00Low Oct. 16, 2026; high Nov. 4, 2025
Average daily volume
851,379Past 3 months
Market value
$2.37B
Dividend yield
—
From 52-week high
−28.47%

Price change

1 month
−4.43%
3 months
−11.75%
Year to date
−17.97%
1 year
−22.83%

$1,000 a year ago

$1,000 put into SUPN at the close on Oct. 24, 2025 would be worth $772.

Price only, dividends not included.

What Wall Street says about SUPN

No Wall Street firm has published a rating or price-target change on SUPN in the past 90 days.

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Headquarters
Rockville, Md.
Employees
778
Listed
May 1, 2012
Sector
Health care
Industry
Pharmaceutical preparations

supernus.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about SUPN is on the site yet.

  • LLYEli Lilly & Co.
  • JNJJohnson & Johnson
  • ABBVABBVIE INC.
  • MRKMerck & Co., Inc.
  • ABTAbbott Laboratories
  • PFEPfizer Inc.